Roberto Luksch

Author PubWeight™ 53.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Youth Project at the Istituto Nazionale Tumori in Milan. Tumori 2012 1.98
2 Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 2005 1.61
3 Prolonged 14-day continuous infusion of high-dose ifosfamide with an external portable pump: feasibility and efficacy in refractory pediatric sarcoma. Pediatr Blood Cancer 2010 1.50
4 Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clin Cancer Res 2003 1.50
5 High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 2002 1.45
6 Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry. Eur J Cancer 2009 1.44
7 Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients. Cancer Res 2009 1.41
8 Neuroblastoma in adolescents: the Italian experience. Cancer 2006 1.19
9 Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry. J Clin Oncol 2010 1.18
10 Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors. Int J Radiat Oncol Biol Phys 2007 1.06
11 Adult Wilms' tumor: A monoinstitutional experience and a review of the literature. Cancer 2004 1.05
12 Medulloblastoma in young children. Pediatr Blood Cancer 2010 1.03
13 Retrospective study of childhood ganglioneuroma. J Clin Oncol 2008 1.02
14 Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 2008 1.02
15 Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Cancer Chemother Pharmacol 2007 1.01
16 Comparison of the prognostic value of assessing tumor diameter versus tumor volume at diagnosis or in response to initial chemotherapy in rhabdomyosarcoma. J Clin Oncol 2010 0.98
17 Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006). Cancer 2012 0.97
18 Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size. J Clin Oncol 2008 0.97
19 Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma. Anticancer Res 2008 0.96
20 A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma. Cancer 2003 0.96
21 Neuroblastoma in patients over 12 years old: a 20-year experience at the Istituto Nazionale Tumori of Milan. Tumori 2011 0.96
22 Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma. Cancer 2002 0.96
23 The symptom interval in children and adolescents with soft tissue sarcomas. Cancer 2010 0.95
24 Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol 2002 0.95
25 Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study. J Clin Oncol 2014 0.94
26 Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. Cancer Res 2003 0.93
27 Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma. Neuro Oncol 2005 0.92
28 Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy. Int J Radiat Oncol Biol Phys 2005 0.90
29 Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma. Diagn Mol Pathol 2004 0.89
30 Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 2008 0.88
31 Psychological support in children and adolescents with cancer when amputation is required. Med Pediatr Oncol 2002 0.87
32 No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Int J Radiat Oncol Biol Phys 2008 0.87
33 Ewing sarcoma of the bone in children under 6 years of age. PLoS One 2013 0.86
34 Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone. Am J Surg Pathol 2003 0.86
35 Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines. BMC Cancer 2011 0.84
36 Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees. BMC Cancer 2012 0.83
37 Evidence for activation of KIT, PDGFRalpha, and PDGFRbeta receptors in the Ewing sarcoma family of tumors. Cancer 2007 0.83
38 End of life in children with cancer: experience at the pediatric oncology department of the istituto nazionale tumori in Milan. Pediatr Blood Cancer 2010 0.83
39 Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment. J Pediatr Hematol Oncol 2012 0.83
40 Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma. J Neurooncol 2012 0.82
41 Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma. Med Sci Monit 2009 0.81
42 Clinical experience with psychological aspects in pediatric patients amputated for malignancies. Tumori 2004 0.80
43 Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age. J Chemother 2013 0.79
44 Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant. Leuk Lymphoma 2011 0.79
45 Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan. J Otolaryngol 2006 0.78
46 Peripheral blood stem cell collection in pediatric patients: feasibility of leukapheresis under anesthesia in uncompliant small children with solid tumors. J Clin Apher 2006 0.78
47 Clinical stage I nonseminomatous germ cell tumors of the testis in childhood and adolescence: an analysis of 31 cases. J Pediatr Hematol Oncol 2002 0.78
48 Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors. Pediatr Hematol Oncol 2005 0.78
49 A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients. Transfusion 2011 0.77
50 Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry. Anticancer Res 2006 0.77
51 Post-relapse survival in patients with Ewing sarcoma. Pediatr Blood Cancer 2015 0.76
52 Assistance to parents who have lost their child with cancer. Tumori 2006 0.76
53 A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients. Transfusion 2012 0.76
54 Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer 2008 0.76
55 Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients. Cancer Chemother Pharmacol 2010 0.76
56 Dramatic response to Cisplatin window therapy in a boy with advanced metastatic ewing sarcoma. J Pediatr Hematol Oncol 2013 0.75
57 Skeletal involvement in infants with neuroblastoma a quality control attempt. Tumori 2007 0.75
58 Identification of novel prognostic markers in relapsing localized resectable neuroblastoma. OMICS 2011 0.75
59 Thyroid carcinoma after treatment for malignancies in childhood and adolescence: from diagnosis through follow-up. Med Oncol 2014 0.75
60 How far can we go with surgery in metastatic osteosarcoma patients? Med Oncol 2015 0.75
61 Psychological assessment of women on an early breast screening program after radiotherapy to the chest wall for childhood cancer. Tumori 2008 0.75
62 Neuroblastoma with symptomatic epidural compression in the infant: the AIEOP experience. Pediatr Blood Cancer 2014 0.75
63 Five questions for assessing psychological problems in pediatric patients cured of neoplastic disease. Pediatr Hematol Oncol 2004 0.75
64 Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents. Med Oncol 2014 0.75
65 Unusual sites of Ewing sarcoma (ES): a retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG). Eur J Cancer 2013 0.75
66 Presacral cystic neuroblastoma: case report and review of the literature. J Pediatr Hematol Oncol 2006 0.75
67 Evolving treatment strategies for parameningeal rhabdomyosarcoma: the experience of the Istituto Nazionale Tumori of Milan. Head Neck 2005 0.75
68 [Adolescents with cancer: the "Youth Project" at the Istituto Nazionale Tumori in Milan]. Recenti Prog Med 2013 0.75